Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
CUSIP: 22663K107
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 94,401,153
- Total 13F shares
- 18,931,321
- Share change
- +1,215,942
- Total reported value
- $473,283,223
- Price per share
- $25.00
- Number of holders
- 63
- Value change
- +$31,131,935
- Number of buys
- 41
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 22663K107?
CUSIP 22663K107 identifies CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22663K107:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.8%
|
3,614,288
|
$82,262,000 | — | 31 Mar 2019 | |
| Vivo Capital, LLC |
13F
|
Company |
3.6%
|
3,375,169
|
$76,819,000 | — | 31 Mar 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.7%
|
2,587,953
|
$58,901,000 | — | 31 Mar 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2%
|
1,914,282
|
$43,569,000 | — | 31 Mar 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2%
|
1,875,209
|
$42,680,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.82%
|
777,974
|
$17,708,000 | — | 31 Mar 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.52%
|
488,367
|
$11,115,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.51%
|
486,130
|
$11,064,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.48%
|
452,212
|
$10,292,000 | — | 31 Mar 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
384,000
|
$8,740,000 | — | 31 Mar 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.31%
|
290,000
|
$6,600,000 | — | 31 Mar 2019 | |
| Artal Group S.A. |
13F
|
Company |
0.21%
|
200,000
|
$4,552,000 | — | 31 Mar 2019 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.18%
|
167,700
|
$3,817,000 | — | 31 Mar 2019 | |
| Novo Holdings A/S |
13F
|
Company |
0.14%
|
135,009
|
$3,073,000 | — | 31 Mar 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.14%
|
131,250
|
$2,987,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
105,399
|
$2,399,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
104,329
|
$2,375,000 | — | 31 Mar 2019 | |
| EMORY UNIVERSITY |
13F
|
Company |
0.1%
|
97,035
|
$2,209,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
90,192
|
$2,052,000 | — | 31 Mar 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
0.08%
|
73,000
|
$1,661,000 | — | 31 Mar 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.06%
|
53,370
|
$1,215,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
43,416
|
$988,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
40,217
|
$916,000 | — | 31 Mar 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
34,062
|
$775,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
29,944
|
$682,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
25,978
|
$591,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
14,391
|
$328,000 | — | 31 Mar 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
13,309
|
$303,000 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.01%
|
11,836
|
$269,000 | — | 31 Mar 2019 | |
| HERSHEY TRUST CO |
13F
|
Company |
0.01%
|
10,947
|
$249,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
10,200
|
$232,000 | — | 31 Mar 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
9,776
|
$223,000 | — | 31 Mar 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
9,500
|
$216,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
9,281
|
$211,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
9,346
|
$210,000 | — | 31 Mar 2019 | |
| ProShare Advisors LLC |
13F
|
Company |
0.01%
|
9,098
|
$207,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
8,888
|
$202,000 | — | 31 Mar 2019 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
7,934
|
$181,000 | — | 31 Mar 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
5,478
|
$125,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
5,322
|
$121,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
4,100
|
$93,000 | — | 31 Mar 2019 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
3,161
|
$72,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,982
|
$67,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,710
|
$61,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,087
|
$48,000 | — | 31 Mar 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0%
|
1,911
|
$43,000 | — | 31 Mar 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,848
|
$42,060 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,463
|
$33,000 | — | 31 Mar 2019 | |
| TIVERTON ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
1,208
|
$27,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,069
|
$24,000 | — | 31 Mar 2019 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q2 2019
As of 30 Jun 2019,
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,931,321 shares.
The largest 10 holders included
FMR LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
62
Q2 2019 holders
63
Holder diff
1
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.